Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Hangeoreum: A Self-Paced Web-Based Program for Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older

29. oktober 2026 opdateret af: Areum Han, University of South Florida

Hangeoreum Program: A Pilot Study of a Self-Paced, Web-Based Program to Address Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older

The goal of this clinical trial is to learn whether Hangeoreum, a culturally tailored, self-paced, web-based program, is feasible and acceptable for Korean immigrants aged 50 and older who experience loneliness, and whether participants report improvements in loneliness and other aspects of psychosocial well-being after using the program. Hangeoreum is based on acceptance and commitment therapy (ACT), which teaches practical skills to help people respond to difficult thoughts and feelings while taking meaningful actions guided by their personal values.

The main questions this study aims to answer are:

  • Can participants complete the Hangeoreum program as planned?
  • Is the program feasible, acceptable, appropriate, and easy to use?
  • Do participants show reductions in loneliness and improvements in social connectedness and other psychosocial outcomes after completing the program?
  • What are participants' experiences with the program, and what suggestions do they have for improving it?

Participants will:

  • Complete six self-paced weekly online modules over approximately 6-7 weeks.
  • Complete online questionnaires before starting and after completing the program.
  • Take part in one online interview about their experiences with the program.

Studieoversigt

Status

Status

Angiver den aktuelle rekrutteringsstatus eller den udvidede adgangsstatus.
Ikke rekrutterer endnu

Betingelser

Betingelser

Den sygdom, lidelse, syndrom, sygdom eller skade, der undersøges. På ClinicalTrials.gov kan tilstande også omfatte andre sundhedsrelaterede problemer, såsom levetid, livskvalitet og sundhedsrisici.

Intervention / Behandling

Intervention / Behandling

En proces eller handling, der er i fokus for en klinisk undersøgelse. Interventioner omfatter lægemidler, medicinsk udstyr, procedurer, vacciner og andre produkter, der enten er til undersøgelse eller allerede er tilgængelige. Interventioner kan også omfatte ikke-invasive tilgange, såsom uddannelse eller ændring af kost og motion.

Detaljeret beskrivelse

Older Korean immigrants in the United States may experience loneliness and limited social connectedness due to cultural and language barriers, limited social support, and challenges associated with immigration and aging. They may also face barriers to accessing culturally and linguistically appropriate mental health resources. Hangeoreum is a research-developed, culturally tailored, self-paced, web-based acceptance and commitment therapy (ACT) program designed to address loneliness and promote meaningful connections and psychosocial well-being among Korean immigrants aged 50 and older. The program was developed based on the ACT psychological flexibility model and findings from a prior qualitative study involving 21 Korean immigrants aged 50 and older. This is a one-group, pretest-posttest mixed-methods pilot study conducted fully online. Approximately 40 Korean immigrants aged 50 and older who experience loneliness will participate. All enrolled participants will receive access to the Hangeoreum program. The study will evaluate preliminary changes in loneliness and other psychosocial outcomes, assess feasibility and user experience, and identify recommendations for program improvement. Hangeoreum includes six culturally tailored, self-paced weekly ACT modules delivered in Korean through the University of South Florida (USF) Canvas learning management system. Each module takes approximately 15-20 minutes to complete and includes brief educational materials, audio recordings, images, worksheets, culturally relevant examples, reflection questions, and ACT skills training exercises. The modules focus on recognizing responses to loneliness, stepping back from unhelpful thoughts, making space for difficult emotions, developing present-moment awareness, identifying personal values and meaningful connections, and taking small, values-based actions to promote connectedness and engagement in daily life. Recruitment will occur through Korean community organizations and networks across the United States, including Korean churches and social service organizations. Interested individuals will contact the study team or complete an online eligibility screening survey. Eligible individuals will complete electronic informed consent and pretest questionnaires online. After completing baseline procedures, participants will receive access to the Hangeoreum program using study-specific login credentials. Participants will be encouraged to complete approximately one module per week over 6-7 weeks. After completing the program modules, participants will complete posttest questionnaires online and participate in a one-time individual interview. Interviews will be conducted in Korean and recorded using the HIPAA-compliant version of Microsoft Teams. Interviews are expected to last approximately 40 minutes. Pretest and posttest questionnaires will be used to explore changes in loneliness, social connectedness, depressive symptoms, anxiety, perceived stress, and ACT-related processes, including psychological flexibility, experiential avoidance, cognitive fusion, and values-based engagement. Posttest implementation measures will assess perceived acceptability, appropriateness, feasibility, and usability. Feasibility will be evaluated using recruitment, retention, and adherence indicators, including program completion rates and reasons for ineligibility and dropout. The Canvas course will capture program engagement metrics, such as course access, time spent, and module completion, as well as responses to in-program activities for research purposes. Qualitative interviews will be used to understand participants' experiences, perceived benefits, cultural relevance, usability challenges, and recommendations for refining the program and study procedures. Analyses will focus on feasibility and descriptive characterization of program engagement. Pre-to-post changes in psychosocial outcomes and ACT-related processes will be explored to identify preliminary patterns of change. Interview data will be analyzed to identify common experiences, perceived benefits, barriers, and suggestions for program improvement. Because this is a single-group pilot study without a comparison group, findings related to psychosocial changes will be considered preliminary rather than definitive evidence of intervention effectiveness. All data will be collected electronically using university-approved secure platforms, including Qualtrics, the Hangeoreum program hosted on USF Canvas, and HIPAA-compliant Microsoft Teams. Hangeoreum is not publicly available and will be accessible only to enrolled participants using study-specific login credentials. Identifying information will be collected only as needed for study-related communication and administrative purposes and stored separately from research data. Study data will be stored in secure, access-controlled USF systems, including USF Box, with access restricted to authorized study personnel. Only de-identified findings, including anonymized interview quotations, will be used in presentations and publications.

Undersøgelsestype

Undersøgelsestype

Beskriver karakteren af ​​en klinisk undersøgelse. Undersøgelsestyper omfatter interventionelle undersøgelser (også kaldet kliniske forsøg), observationsundersøgelser (herunder patientregistre) og udvidet adgang.
Interventionel

Tilmelding (Anslået)

Tilmelding

Antallet af deltagere i en klinisk undersøgelse. Den "forventede" tilmelding er det mål for antallet af deltagere, som forskerne skal bruge til undersøgelsen.
40

Fase

Fase

Stadiet af et klinisk forsøg, der studerer et lægemiddel eller et biologisk produkt, baseret på definitioner udviklet af U.S. Food and Drug Administration (FDA). Fasen tager udgangspunkt i undersøgelsens formål, antallet af deltagere og andre karakteristika. Der er fem faser: Tidlig fase 1 (tidligere opført som fase 0), fase 1, fase 2, fase 3 og fase 4. Ikke relevant bruges til at beskrive forsøg uden FDA-definerede faser, herunder forsøg med enheder eller adfærdsmæssige indgreb.
  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiekontakt

Navn og kontaktoplysninger for den person, der kan besvare spørgsmål om tilmelding til en klinisk undersøgelse. Hvert sted, hvor undersøgelsen udføres, kan også have en specifik kontaktperson, som kan være bedre i stand til at besvare disse spørgsmål.

Undersøgelse Kontakt Backup

Studiesteder

  • Forenede Stater
    • Florida
      • Tampa, Florida, Forenede Stater, 33612
        • University of South Florida
        • Kontakt:
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Berettigelseskriterier

De nøglekrav, som personer, der ønsker at deltage i et klinisk studie, skal opfylde eller de egenskaber, de skal have. Kvalifikationskriterier består af både inklusionskriterier (som er nødvendige for at en person kan deltage i undersøgelsen) og eksklusionskriterier (som forhindrer en person i at deltage). Typer af berettigelseskriterier omfatter, om en undersøgelse accepterer raske frivillige, har alders- eller aldersgruppekrav eller er begrænset af køn.

Aldre berettiget til at studere

50 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion criteria are: (1) being 50 years of age or older; (2) self-identifying as a Korean immigrant, defined as being born in Korea and having immigrated to the United States; (3) being fluent in Korean; (4) reporting feelings of loneliness, defined for screening purposes as a score of ≥ 5 on the Korean version of the 3-item UCLA Loneliness Scale, with brief phone verification by the study team when needed to clarify incomplete or unclear screening responses; and (5) having access to a web-enabled device, such as a smartphone, tablet, laptop, or desktop computer, with internet access at home or in the community (e.g., a public library or church).

Exclusion criteria are: (1) cognitive, physical, or sensory limitations that cannot be accommodated and would prevent meaningful participation in study procedures, including a diagnosis of dementia or another condition affecting cognitive abilities; (2) suicidal ideation, intent, or attempts within the past 6 months; and (3) participation in another clinical trial at the time of recruitment.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm

Deltagergruppe / Arm

En gruppe eller undergruppe af deltagere i et klinisk forsøg, der modtager en specifik intervention/behandling eller ingen intervention i henhold til forsøgets protokol.
Intervention / Behandling

Intervention / Behandling

En proces eller handling, der er i fokus for en klinisk undersøgelse. Interventioner omfatter lægemidler, medicinsk udstyr, procedurer, vacciner og andre produkter, der enten er til undersøgelse eller allerede er tilgængelige. Interventioner kan også omfatte ikke-invasive tilgange, såsom uddannelse eller ændring af kost og motion.
Eksperimentel: Hangeoreum (Web-Based ACT) Group

Participants will complete the Hangeoreum program, a culturally tailored, Korean-language, self-paced, web-based acceptance and commitment therapy (ACT) program consisting of six weekly online modules over approximately 6-7 weeks.
Adfærdsmæssigt: Hangeoreum

Six culturally tailored, self-paced weekly ACT modules delivered in Korean, approximately 15-20 minutes each, focusing on psychological flexibility and meaningful connectedness.

Hvad måler undersøgelsen?

Primære resultatmål

Primære resultatmål

I et klinisk studies protokol er det planlagte resultatmål, der er det vigtigste for at evaluere effekten af ​​en intervention/behandling. De fleste kliniske undersøgelser har ét primært resultatmål, men nogle har mere end ét.
Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Enrollment rate
Tidsramme: From the start of recruitment through completion of enrollment, up to 6 months.

The enrollment rate will be calculated as the number of participants who provide informed consent and complete the baseline assessment divided by the number of eligible individuals invited to participate in the study.
From the start of recruitment through completion of enrollment, up to 6 months.
Retention
Tidsramme: Baseline through post-intervention (approximately 6-7 weeks)

Retention will be defined as the proportion of enrolled participants who complete the post-intervention assessment.
Baseline through post-intervention (approximately 6-7 weeks)
Web-based module completion
Tidsramme: Baseline through post-intervention (approximately 6-7 weeks)

Web-based module completion will be defined as the number of Hangeoreum modules completed by each participant (range 0-6 modules). Module completion will be determined based on completion of the module completion survey at the end of each module, as recorded in Canvas.
Baseline through post-intervention (approximately 6-7 weeks)

Sekundære resultatmål

Sekundære resultatmål

I en klinisk undersøgelses protokol er et planlagt resultatmål, der ikke er lige så vigtigt som det primære resultatmål for at evaluere effekten af ​​en intervention, men som stadig er af interesse. De fleste kliniske undersøgelser har mere end ét sekundært resultatmål.
Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Acceptability of the Hangeoreum Program
Tidsramme: Post-intervention (approximately 6-7 weeks)

Acceptability will be assessed using the Acceptability of Intervention Measure (AIM). AIM includes four items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Mean scale scores range from 1 to 5, with higher scores indicating greater perceived acceptability.
Post-intervention (approximately 6-7 weeks)
Appropriateness of the Hangeoreum program
Tidsramme: Post-intervention (approximately 6-7 weeks)

Appropriateness will be assessed using the Intervention Appropriateness Measure (IAM). IAM includes four items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Mean scale scores range from 1 to 5, with higher scores indicating greater perceived appropriateness.
Post-intervention (approximately 6-7 weeks)
Perceived feasibility of the Hangeoreum program
Tidsramme: Post-intervention (approximately 6-7 weeks)

Perceived feasibility will be assessed using the Feasibility of Intervention Measure (FIM). FIM includes four items rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Mean scale scores range from 1 to 5, with higher scores indicating greater perceived feasibility.
Post-intervention (approximately 6-7 weeks)
Usability of the Hangeoreum program
Tidsramme: Post-intervention (approximately 6-7 weeks)

Usability will be assessed using the System Usability Scale (SUS). SUS includes 10 items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Responses will be scored using standard SUS procedures to generate a total score ranging from 0 to 100, with higher scores indicating better perceived usability.
Post-intervention (approximately 6-7 weeks)
Change in UCLA Loneliness Scale Version 3 (UCLA-LS) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The UCLA Loneliness Scale Version 3 (UCLA-LS) is a 20-item self-report questionnaire assessing subjective feelings of loneliness and social isolation. Items are rated on a 4-point scale (1 = never to 4 = often). After appropriate reverse scoring, total scores range from 20 to 80, with higher scores indicating greater loneliness.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Social Connectedness Scale-Revised (SCS-R) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The Social Connectedness Scale-Revised (SCS-R) is a 20-item self-report questionnaire assessing individuals' sense of interpersonal closeness and connectedness with others. Items are rated on a 6-point scale (1 = strongly disagree to 6 = strongly agree). After appropriate reverse scoring, total scores range from 20 to 120, with higher scores indicating greater social connectedness.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Patient Health Questionnaire-9 (PHQ-9) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The PHQ-9 is a nine-item self-report questionnaire assessing depressive symptoms over the past two weeks. Items are rated from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Generalized Anxiety Disorder-7 (GAD-7) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The GAD-7 is a seven-item self-report questionnaire assessing anxiety symptoms over the past two weeks. Items are rated from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptoms.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Perceived Stress Scale-10 (PSS-10) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The PSS-10 is a 10-item self-report questionnaire assessing perceived stress over the past month. Items are rated from 0 (never) to 4 (very often). After appropriate reverse scoring, total scores range from 0 to 40, with higher scores indicating greater perceived stress.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Brief Experiential Avoidance Questionnaire (BEAQ) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The BEAQ is a 15-item self-report questionnaire assessing experiential avoidance, or the tendency to avoid unwanted thoughts, feelings, and experiences. Items are rated on a 6-point scale (1 = strongly disagree to 6 = strongly agree). Total scores range from 15 to 90, with higher scores indicating greater experiential avoidance.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Cognitive Fusion Questionnaire-7 (CFQ-7) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The CFQ-7 is a seven-item self-report questionnaire measuring cognitive fusion, or the extent to which individuals become entangled with their thoughts. Items are rated from 1 (never true) to 7 (always true). Total scores range from 7 to 49, with higher scores indicating greater cognitive fusion.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Engaged Living Scale-9 (ELS-9) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The ELS-9 is a nine-item self-report questionnaire assessing values-based living, including clarity of personal values and engagement in meaningful activities. Items are rated on a 5-point scale (1 = completely disagree to 5 = completely agree). Total scores range from 9 to 45, with higher scores indicating greater values-based engagement.
Baseline to post-intervention (approximately 6-7 weeks)
Change in Multidimensional Psychological Flexibility Inventory-24 (MPFI-24) scores from baseline to post-intervention
Tidsramme: Baseline to post-intervention (approximately 6-7 weeks)

The MPFI-24 is a 24-item self-report questionnaire assessing multidimensional psychological flexibility and inflexibility processes. Items are rated on a 6-point scale (1 = never true to 6 = always true). Psychological flexibility and psychological inflexibility are represented by separate composite scores, with higher scores indicating greater levels of the respective construct.
Baseline to post-intervention (approximately 6-7 weeks)

Andre resultatmål

Andre resultatmål

For kliniske forsøg en planlagt måling beskrevet i protokollen, der bruges til at bestemme effekten af ​​en intervention/behandling på deltagerne. Til observationsstudier, en måling eller observation, der bruges til at beskrive mønstre af sygdomme eller egenskaber eller sammenhænge med eksponeringer, risikofaktorer eller behandling. Typer af resultatmål omfatter primært resultatmål og sekundært resultatmål.
Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
User Experiences (Semi-structured Individual Interviews)
Tidsramme: Post-intervention (approximately 6-7 weeks)

Individual semi-structured interviews (approximately 40 minutes) will be conducted in Korean via videoconference after program completion. Interviews will explore participants' experiences with Hangeoreum, perceived changes in loneliness and connectedness, cultural relevance, program usability and accessibility, perceived benefits, and suggestions for program improvement. Interview data will be analyzed using thematic analysis.
Post-intervention (approximately 6-7 weeks)
Participant Perceptions of the Hangeoreum Weekly Modules
Tidsramme: Post-intervention (approximately 6-7 weeks)

Twelve additional program feedback items will assess participants' perceptions of the weekly modules, including clarity, ease of use, cultural relevance, visual design, engagement, perceived usefulness, manageability, and overall satisfaction. Items are rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Item-level ratings will be summarized descriptively, with higher scores indicating more favorable perceptions.
Post-intervention (approximately 6-7 weeks)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Sponsor

Den organisation eller person, der igangsætter undersøgelsen, og som har myndighed og kontrol over undersøgelsen.
University of South Florida

Samarbejdspartnere

Samarbejdspartnere

En anden organisation end sponsoren, der yder støtte til en klinisk undersøgelse. Denne støtte kan omfatte aktiviteter relateret til finansiering, design, implementering, dataanalyse eller rapportering.
RRF Foundation for Aging

Efterforskere

Efterforskere

En forsker involveret i et klinisk studie. Beslægtede termer omfatter stedets principal investigator, site sub-investigator, studieformand, undersøgelsesleder og undersøgelseshovedinvestigator.
  • Ledende efterforsker: Areum Han, PhD, University of South Florida

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

Studiestart

Den faktiske dato, hvor den første deltager blev tilmeldt en klinisk undersøgelse. Den "forventede" undersøgelses startdato er den dato, som forskerne tror vil være undersøgelsens startdato.
1. november 2026

Primær færdiggørelse (Anslået)

Primær færdiggørelse

Den dato, hvor den sidste deltager i et klinisk studie blev undersøgt eller modtog en intervention for at indsamle endelige data for det primære resultatmål. Hvorvidt det kliniske studie sluttede i henhold til protokollen eller blev afsluttet, påvirker ikke denne dato. For kliniske undersøgelser med mere end ét primært resultatmål med forskellige afslutningsdatoer refererer dette udtryk til den dato, hvor dataindsamlingen er afsluttet for alle de primære resultatmål. Den "forventede" primære afslutningsdato er den dato, som forskerne tror vil være den primære afslutningsdato for undersøgelsen.
1. april 2027

Studieafslutning (Anslået)

Studieafslutning

Den dato, hvor den sidste deltager i et klinisk studie blev undersøgt eller modtog en intervention/behandling for at indsamle endelige data for de primære resultatmål, sekundære udfaldsmål og uønskede hændelser (det vil sige den sidste deltagers sidste besøg). Den "forventede" undersøgelses afslutningsdato er den dato, som forskerne tror vil være undersøgelsens afslutningsdato.
1. april 2027

Datoer for studieregistrering

Først indsendt

Først indsendt

Den dato, hvor undersøgelsens sponsor eller investigator første gang indsendte en undersøgelsespost til ClinicalTrials.gov. Der er typisk en forsinkelse på et par dage mellem den første indsendte dato og postens tilgængelighed på ClinicalTrials.gov (den første offentliggjorte dato).
25. oktober 2026

Først indsendt, der opfyldte QC-kriterier

Først indsendt, der opfyldte QC-kriterier

Den dato, hvor undersøgelsens sponsor eller investigator første gang indsender en undersøgelsespost, der er i overensstemmelse med National Library of Medicine (NLM) kvalitetskontrol (QC) gennemgangskriterier. Sponsoren eller investigatoren skal muligvis revidere og indsende en undersøgelsespost en eller flere gange, før NLM's kvalitetskontrolkriterier er opfyldt. Det er sponsorens eller investigatorens ansvar at sikre, at undersøgelsesposten er i overensstemmelse med NLM QC-gennemgangskriterierne.
29. oktober 2026

Først opslået (Faktiske)

Først opslået

Datoen, hvor undersøgelsesposten først var tilgængelig på ClinicalTrials.gov efter National Library of Medicine (NLM) kvalitetskontrol (QC) gennemgang er afsluttet. Der er typisk en forsinkelse på et par dage mellem den dato, hvor undersøgelsens sponsor eller investigator indsendte undersøgelsesposten, og den første offentliggjorte dato.
4. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

Sidste opdatering sendt

Den seneste dato, hvor ændringer i en undersøgelsespost blev gjort tilgængelig på ClinicalTrials.gov. Der kan være en forsinkelse mellem det tidspunkt, hvornår ændringerne blev indsendt til ClinicalTrials.gov af undersøgelsens sponsor eller investigator (datoen for sidste opdatering afsendt) og den sidste opdatering, der blev sendt.
4. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

Den seneste dato, hvor undersøgelsens sponsor eller investigator indsendte ændringer til en undersøgelsespost, der er i overensstemmelse med National Library of Medicine (NLM) kvalitetskontrol (QC) gennemgangskriterier. Det er sponsorens eller investigatorens ansvar at sikre, at undersøgelsesposten er i overensstemmelse med NLM QC-gennemgangskriterierne.
29. oktober 2026

Sidst verificeret

Sidst verificeret

Den seneste dato, hvor undersøgelsens sponsor eller investigator bekræftede oplysningerne om en klinisk undersøgelse på ClinicalTrials.gov som nøjagtige og aktuelle. Hvis en undersøgelse med rekrutteringsstatus som rekruttering; rekrutterer endnu ikke; eller aktiv, ikke rekruttering er ikke blevet bekræftet inden for de seneste 2 år, er undersøgelsens rekrutteringsstatus vist som ukendt.
1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

Andre undersøgelses-id-numre

Andre identifikatorer eller ID-numre end NCT-nummeret, der er tildelt til en klinisk undersøgelse af undersøgelsens sponsor, finansieringsgivere eller andre. Disse numre kan omfatte unikke identifikatorer fra andre forsøgsregistre og National Institutes of Health-bevillingsnumre.
  • STUDY010478
  • 2024026 (Andet bevillings-/finansieringsnummer: Retirement Research Foundation)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Cookieindstillinger

Vi bruger cookies for at sikre, at vi giver dig den bedste oplevelse på vores hjemmeside. For flere detaljer skal du læse omhyggeligt vores Politik om beskyttelse af personlige oplysninger og cookies. ...>>>Du kan når som helst ændre dine præferencer eller trække dit samtykke tilbage ved at slette cookies fra din hjemmeside eller computer som beskrevet i politikken. Accepter det og vælg dine præferencer ved at markere de tilsvarende felter i afsnittet "Administrer indstillinger" nedenfor. Læs vores servicevilkår omhyggeligt, inden du fortsætter med at bruge nogen del af dette websted.
«Administrer indstillinger